ArticleBritish journal of cancer2011
Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland.
Article in British journal of cancer, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy.BMJ (Clinical research ed.) · 2021Pooled it
- Radiologists can detect the 'gist' of breast cancer before any overt signs of cancer appear.Scientific reports · 2018Trial
- A comparison of tumour characteristics of screen-detected and interval cancers and their relationship with breast density and AJCC prognostic stage in a UK screening cohort.European radiology · 2026Article
- Performance of breast cancer risk prediction algorithms across mammography systems in the UK screening programme.NPJ digital medicine · 2026Article
- A guide to cancer screening.Nature reviews. Clinical oncology · 2026Review
- Article
- The influence of breast screening on breast cancer incidence in England: observational study based on cancer registries and bulletins of the NHS Breast Screening Programme.European journal of public health · 2024Observational
- Lessons Learnt from Imaging Review of Interval Breast Cancers in a Single Center in the UK National Breast Screening Program.The Indian journal of radiology & imaging · 2024Article
- Genetic landscape of interval and screen detected breast cancer.NPJ precision oncology · 2024Article
- Risk Factors and Mortality Among Women With Interval Breast Cancer vs Screen-Detected Breast Cancer.JAMA network open · 2024Article
- Fatigue and vigilance in medical experts detecting breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2024Article
- Patient counseling for breast cancer screening: Taking changes to USPSTF recommendations into account.OBG management · 2023Article
- Recovery of the breast screening programme following pandemic-related delays: Should we focus on round length or uptake?Journal of medical screening · 2022Article
- Article
- Evaluation of breast stiffness pathology based on breast compression during mammography: Proposal for novel breast stiffness scale classification.Clinics (Sao Paulo, Brazil) · 2022Article
- Breast cancer screening with mammography in women aged 40-49 years: Impact of length of screening interval on effectiveness of the program.Journal of medical screening · 2021Article
- Breast Cancer Screening in Asian Women with Dense Breast by Mammography: A Cross-Sectional Observational Study.Asian Pacific journal of cancer prevention : APJCP · 2021Observational
- Association of symptoms and interval breast cancers in the mammography-screening programme: population-based matched cohort study.British journal of cancer · 2018Article
- Association between Screening Mammography Recall Rate and Interval Cancers in the UK Breast Cancer Service Screening Program: A Cohort Study.Radiology · 2018Article
- Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening.BMC cancer · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe United Kingdom NHS Breast Screening Programme was established in 1988, and women aged between 50 and 70 are routinely invited at three yearly intervals. Expected United Kingdom interval cancer rates have been calculated previously, but this is the first publication from an exercise to collate individual-based interval cancer data at a national level.
methodsInterval cancer case ascertainment is achieved by the regular exchange of data between Regional Breast Screening Quality Assurance Reference Centres and Cancer Registries. The present analysis includes interval cancers identified in women screened between 1st April 1997 and 31st March 2003, who were aged between 50 and 64 at the time of their last routine screen.
resultsIn the periods >0-<12 months, 12-<24 months and 24-<36 months after a negative screen, we found overall interval cancer rates and regional ranges of 0.55 (0.43-0.76), 1.13 (0.92-1.47) and 1.22 (0.93-1.57) per 1000 women screened, respectively. Rates in the period 33-<36 months showed a decline, possibly associated with early re-screening or delayed presentation.
conclusionsInterval cancer rates were higher than the expected rates in the 24-month period after a negative screen, but were similar to published results from other countries. Increases in background incidence may mean that the expected rates are underestimated. It is also possible that, as a result of incomplete case ascertainment, interval cancers rates were underestimated in some regions in which rates were less than the expected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.